UP!

CANF $2.18   View long term graphs

News

Can-Fite BioPharma Ltd. -0.28% (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2019 2019-12-27 0.00 -0.90
Q2 2019 2019-08-29 -0.08 -1.20
Q1 2019 2019-06-10 -0.08 -18.00
Q4 2018 2019-04-12 -2.70 -2.70
Q3 2018 2019-01-17 0.00 0.00

Ratings

2016-04-04 Reiterated Rating HC Wainwright Buy $6.00
2016-01-07 Reiterated Rating HC Wainwright Buy $6.00
2015-11-30 Reiterated Rating HC Wainwright Buy $4.00 to $6.00
2015-11-24 Reiterated Rating HC Wainwright Buy $4.00 to $6.00
2015-09-01 Reiterated Rating HC Wainwright Buy $4.00
2015-05-03 Reiterated Rating HC Wainwright Buy $3.00 to $4.00
2015-03-31 Lower Price Target HC Wainwright Buy $7.00 to $3.00
2015-03-30 Downgrade Roth Capital Buy to Neutral $20.00 to $2.40
2015-03-18 Set Price Target Roth Capital Buy $20.00
2014-12-29 Lower Price Target Roth Capital Buy $28.00 to $20.00
2014-11-18 Initiated Coverage HC Wainwright Buy $7.00
2013-12-23 Boost Price Target Roth Capital $28.00
2016-04-04 Reiterated Rating HC Wainwright Buy $6.00
2016-01-07 Reiterated Rating HC Wainwright Buy $6.00
2015-11-30 Reiterated Rating HC Wainwright Buy $4.00 to $6.00
2015-11-24 Reiterated Rating HC Wainwright Buy $4.00 to $6.00
2015-09-01 Reiterated Rating HC Wainwright Buy $4.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In CANF 6 funds of 2210 total. Show all

Fund name Ticker shares
TAYLOR ASSET MANAGEMENT INC 0.54M
RENAISSANCE TECHNOLOGIES LLC 0.12M
Virtu Financial LLC 74052
KCG Holdings, Inc. 21565
MORGAN STANLEY 17676
BANK OF MONTREAL /CAN/ 66

Major Shareholders

Name Relationship Total Shares Holding stocks

Comments